TamRx launches to develop pipeline of immuno-oncology products for treatment of cancers

This article was originally published here

The new company will focus on the development of a novel family of small molecule inhibitors designed to block tumor growth and stimulate the immune system to fight

The post TamRx launches to develop pipeline of immuno-oncology products for treatment of cancers appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply